Stockscreener 앱 받기
1.28
0.00%
0.00
시간 외 거래:
1.25
-0.03
-2.34%
전일 마감가:
$1.28
열려 있는:
$1.27
하루 거래량:
585.44K
Relative Volume:
0.31
시가총액:
$234.70M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-8.00
EPS:
-0.16
순현금흐름:
$-9.61M
1주 성능:
+0.79%
1개월 성능:
+13.27%
6개월 성능:
-40.47%
1년 성능:
-18.99%
1일 변동 폭
$1.265
$1.30
1주일 범위
$1.26
$1.40
52주 변동 폭
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
(858) 251-4400
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.28 | 234.70M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.71 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.42 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-23 | 개시 | CapitalOne | Overweight |
| 2024-03-13 | 재확인 | Needham | Buy |
| 2020-05-27 | 개시 | Guggenheim | Buy |
| 2020-02-20 | 재확인 | Needham | Buy |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-04-05 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2018-03-01 | 재확인 | Needham | Buy |
| 2018-01-03 | 개시 | Leerink Partners | Outperform |
| 2017-09-27 | 개시 | Northland Capital | Outperform |
| 2017-02-27 | 개시 | Needham | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-09-06 | 재개 | Lake Street | Buy |
| 2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
| 2015-12-10 | 개시 | Lake Street | Buy |
| 2015-09-23 | 재확인 | Leerink Partners | Outperform |
| 2015-09-02 | 개시 | BofA/Merrill | Buy |
| 2015-08-03 | 재확인 | Brean Capital | Buy |
| 2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
| 2015-06-19 | 재확인 | Leerink Partners | Outperform |
| 2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Investor Mood: Will Heron Therapeutics Inc stock outperform tech sector in 2025Bear Alert & Long Hold Capital Preservation Tips - moha.gov.vn
Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 Weekly Recap & Weekly Top Stock Performers List - Улправда
Is Heron Therapeutics Inc. stock attractive for income investorsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Can Heron Therapeutics Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Detailed Earnings Play Alerts - Улправда
How Heron Therapeutics Inc. stock reacts to global recession fearsWeekly Trend Recap & Community Consensus Picks - Улправда
How supply chain issues affect Heron Therapeutics Inc. stockJuly 2025 Movers & Daily Volume Surge Trade Alerts - Улправда
Is Heron Therapeutics Inc. stock cheap at current valuationJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - DonanımHaber
How analysts rate Heron Therapeutics Inc. stock todayEarnings Risk Report & Expert Verified Stock Movement Alerts - DonanımHaber
Is Heron Therapeutics Inc. stock gaining market shareInflation Watch & Community Consensus Trade Alerts - Улправда
Will Heron Therapeutics Inc. stock gain from strong economyWeekly Earnings Recap & Real-Time Volume Surge Alerts - DonanımHaber
Congress Park Capital LLC Acquires 621,908 Shares of Heron Therapeutics, Inc. $HRTX - Defense World
Heron Therapeutics Earnings Notes - Trefis
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Yahoo Finance
Heron Therapeutics Appoints Thomas Cusack to Board - MSN
Heron Therapeutics Reports Strong Q3 2025 Revenue Growth - MSN
Heron Therapeutics Inc (HRTX) can make a big difference with a little luck - setenews.com
Heron Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Heron Therapeutics enters board agreement and completes refinancing transactions By Investing.com - Investing.com Nigeria
Activity Recap: Will Heron Therapeutics Inc stock deliver long term returnsDividend Hike & Weekly Market Pulse Updates - BỘ NỘI VỤ
San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN
What analysts say about Heron Therapeutics Inc stockGrowth Stock Opportunities & 5 Stocks Every Investor Should Own - earlytimes.in
Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) - simplywall.st
Can Heron Therapeutics Inc. stock sustain institutional interestMarket Trend Report & High Return Trade Guides - Newser
Can Heron Therapeutics Inc. (AXD2) stock expand revenue streamsWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Heron Therapeutics announces inclusion of Aponvie (aprepitant) - marketscreener.com
Heron Therapeutics Announces Inclusion of APONVIE® - GlobeNewswire
Why Heron Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Heron Therapeutics (Nasdaq: HRTX) APONVIE cited in fifth consensus PONV care guidelines - Stock Titan
Heron Therapeutics Injects New Life Into Growth Story With ZYNRELEF And APONVIE Momentum - RTTNews
Will Heron Therapeutics Inc. stock deliver long term returnsCPI Data & Risk Controlled Swing Trade Alerts - Newser
History Review: Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 WrapUp & Daily Profit Focused Screening - BỘ NỘI VỤ
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives $4.50 Average Price Target from Brokerages - Defense World
Heron Therapeutics (HRTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What the Latest News Means for Eurotex Industries and Exports Limited Stock InvestorsProtective Put Strategies & Small Capital Trading Growth - earlytimes.in
What analysts say about Heron Therapeutics Inc AXD2 stockMarket Sentiment Surveys & Build a Dividend-Powered Portfolio - earlytimes.in
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Trading Action: Can Heron Therapeutics Inc. stock surprise with earnings upsideQuarterly Trade Report & High Accuracy Swing Entry Alerts - moha.gov.vn
Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC - MarketBeat
Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Is Heron Therapeutics Inc AXD2 a good long term investmentFundamental Strength Indicators & High Yield Stock Picks - earlytimes.in
Heron Therapeutics, Inc. (HRTX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Can Heron Therapeutics Inc. (AXD2) stock attract ESG investmentsJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Why Heron Therapeutics Inc. (AXD2) stock remains stableWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
How Heron Therapeutics Inc. (AXD2) stock responds to bond marketInsider Buying & AI Enhanced Trading Signals - newser.com
How Heron Therapeutics Inc. (AXD2) stock moves in volatile trading sessionsJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Heron Therapeutics Inc. stock daily chart insightsRecession Risk & Weekly High Potential Stock Alerts - newser.com
Heron Therapeutics Inc (HRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.21%
자본화:
|
볼륨(24시간):